Daraxonrasib trial shrinks pancreatic tumors; undetectable in 1 in 12 patients
Published 1 d ago2 sourcesEvidence: Reported
A Cleveland Clinic study reports that a single injection targeting two distinct cholesterol pathways produced strong initial results in reducing high cholesterol. The findings are preliminary and not yet peer-reviewed or published in full, so efficacy and safety remain uncertain. If confirmed, this could shift lipid-management treatment paradigms, but it is too early to assess clinical or market impact.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 16 h ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 5 h ago2 sourcesEvidence: Reported